Unknown

Dataset Information

0

6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.

ABSTRACT: Following a ligand-based drug design approach, a potent mixed formyl peptide receptor 1 (FPR1) and formyl peptide receptor-like 1 (FPRL1) agonist (14a) and a potent and specific FPRL1 agonist (14x) were identified. These compounds belong to a large series of pyridazin-3(2H)-one derivatives substituted with a methyl group at position 6 and a methoxy benzyl at position 4. At position 2, an acetamide side chain is essential for activity. Likewise, the presence of lipophilic and/or electronegative substituents in the position para to the aryl group at the end of the chain plays a critical role for activity. Affinity for FPR1 receptors was evaluated by measuring intracellular calcium flux in HL-60 cells transfected with FPR1, FPRL1, and FPRL2. Agonists were able to activate intracellular calcium mobilization and chemotaxis in human neutrophils. The most potent chemotactic agent (EC(50) = 0.6 microM) was the mixed FPR/FPRL1 agonist 14h.

SUBMITTER: Cilibrizzi A 

PROVIDER: S-EPMC2888720 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Following a ligand-based drug design approach, a potent mixed formyl peptide receptor 1 (FPR1) and formyl peptide receptor-like 1 (FPRL1) agonist (14a) and a potent and specific FPRL1 agonist (14x) were identified. These compounds belong to a large series of pyridazin-3(2H)-one derivatives substituted with a methyl group at position 6 and a methoxy benzyl at position 4. At position 2, an acetamide side chain is essential for activity. Likewise, the presence of lipophilic and/or electronegative s  ...[more]

Similar Datasets

Unknown Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists.
| S-EPMC3565387 | biostudies-literature
Unknown Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.
| S-EPMC3711119 | biostudies-literature
Unknown 4,5-Dichloro-2-methyl-pyridazin-3(2H)-one.
| S-EPMC2971970 | biostudies-literature
Unknown 6-Methyl-2-phenyl-4,5-dihydro-pyridazin-3(2H)-one.
| S-EPMC3151939 | biostudies-literature
Unknown Diclomezine: 6-(3,5-dichloro-4-methyl-phen-yl)pyridazin-3(2H)-one.
| S-EPMC3011476 | biostudies-literature
Unknown 8-Formyl-4-methyl-2-oxo-2H-chromen-7-yl 4-methyl-benzenesulfonate.
| S-EPMC3120547 | biostudies-literature
Unknown Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway <i>Pseudomonas aeruginosa</i> Infection in Mice.
| S-EPMC6151375 | biostudies-literature
Unknown 3,4,7-Trimethyl-2-(4-methyl-phen-yl)-2H-pyrazolo-[3,4-d]pyridazin-5-ium thio-cyanate.
| S-EPMC3011493 | biostudies-literature
Unknown 6-Methyl-2-p-tolyl-4-[3-(trifluoro-meth-yl)phen-yl]pyridazin-3(2H)-one.
| S-EPMC2961053 | biostudies-literature
Unknown Diaqua-bis(2,4-dichloro-6-formyl-phenolato)zinc(II)-bis-(?-2,4-dichloro-6-formyl-phenolato)bis-[aqua-(2,4-dichloro-6-formyl-phenolato)zinc(II)] (2/1).
| S-EPMC2972068 | biostudies-literature